Novartis, Teva and Mylan to supply around 200 millions of doses of antimalarial drugs to fight against corona virus

Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of COVID-19. Also, there are few results suggested that Hydroxychloroquine is effective against COVID-19. Three pharma giants Novartis, Mylan and Teva Pharma announced that they will donate millions of doses of hydroxychloroquine to support the global COVID-19 pandemic response.

source https://www.pharmatutor.org/pharma-news/2020/novartis-teva-and-mylan-to-supply-around-200-millions-of-doses-of-antimalarial-drugs-to-fight-against-corona-virus